A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia. Issue 6 (June 2015) - Strati, Paolo; Tong, Wei-Gang; Vitale, Candida; Wierda, William G.; O'Brien, Susan; Brown, Jennifer R.; Weng, Wen-Kai; Kipps, Thomas; Keating, Michael J.; Ferrajoli, Alessandra